
    
      After successful percutaneous coronary intervention (PCI) for acute myocardial infarction,
      100 patients are randomly assigned to either a control group (n=50) who receives an optimal
      medical treatment, or a bone-marrow-cell group (n=50) who receives an optimal medical
      treatment and intracoronary transfer of autologous bone-marrow cells 7â€¢10 days after PCI.
    
  